--- title: "Exenatide vs Tirzepatide: Side-by-Side Comparison (2026)" url: https://www.bodyhackguide.co/compare/exenatide-vs-tirzepatide description: "Compare Exenatide vs Tirzepatide side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices." lang: en --- Skip to content Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide) # Exenatide vs Tirzepatide Side-by-side comparison of Exenatide and Tirzepatide: mechanism, half-life, dose range, safety profile, and vendor pricing. Exenatide: no price on file Tirzepatide from $49.00 ## Price snapshot ### Exenatide Current low — 7-day low — not enough history yet 30-day low — not enough history yet 30-day change — not enough history yet ### Tirzepatide Current low $49.00 current listings 7-day low — not enough history yet 30-day low — not enough history yet 30-day change — not enough history yet ## Exenatide Exenatide (Byetta, Bydureon) is a synthetic exendin-4 GLP-1 receptor agonist, FDA-approved for type 2 diabetes, that lowers blood glucose and curbs appetite. Available as a twice-daily immediate-release and a once-weekly… No vendor price on file. Full Exenatide profile (https://www.bodyhackguide.co/compound/exenatide) ## Tirzepatide Featured Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with a molecular weight of 4813.45 Da and CAS number 2023788-19-2. It is a 39-amino-acid… **Lowest listed price:** $49.00 across 14 listings Full Tirzepatide profile (https://www.bodyhackguide.co/compound/tirzepatide) ## Side-by-side comparison | Attribute | Exenatide | Tirzepatide | | --- | --- | --- | | Category | Weight Loss | Metabolic & Weight Loss | | Research Stage | FDA-approved | FDA Approved | | Mechanism of Action | Exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the Gila monster (Heloderma suspectum). It shares about 53 percent of its sequence with human GLP-1 but, unlike native GLP-1, resists breakdown by the DPP-4… | Dual GLP-1 and GIP Receptor Agonism Tirzepatide simultaneously activates two incretin receptors: the GLP-1 receptor and the GIP receptor. While the GLP-1 receptor component provides the well-established effects of GLP-1 agonism (glucose-dependent insulin… | | Half-Life | Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. | ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification | | Typical Dose Range | 5 to 10 mcg twice daily (Byetta, immediate-release) or 2000 mcg (2 mg) once weekly (Bydureon, extended-release) | 2500 mcg (2.5 mg) starting dose, titrated every 4 weeks through 5000, 7500, 10000, 12500, to 15000 mcg (15 mg) maximum weekly dose | | Dosing Frequency | Twice daily before meals (immediate-release) or once weekly (extended-release) | Once weekly subcutaneous injection | | Administration | — | Subcutaneous (weekly) | | Side Effects | Gastrointestinal effects are by far the most common: nausea (reported in roughly 40 to 57 percent of patients on the twice-daily form, usually worst early and fading over weeks), vomiting, diarrhea, constipation, and dyspepsia. Reduced appetite is expected.… | Mild to moderate nausea (especially at initiation), headache, fatigue, constipation or diarrhea, abdominal distension. Injection site reactions. Rare: hypoglycemia, increased heart rate, pancreatitis. | | Molecular Weight | 4186.6 g/mol (molecular formula C184H282N50O60S) | 4813.5 Da | | Common Vial Sizes | — | 5mg, 10mg, 15mg | ## Price History 3 data points - BM - Half Nattys - Ion Peptide ### Exenatide: potential benefits - Meaningful glycemic control in type 2 diabetes, with HbA1c reductions of roughly 1.0 to 1.9 percent in randomized trials - Weight reduction of about 2 to 3 kg in diabetic trials, driven mainly by reduced appetite and slower gastric emptying - Low intrinsic hypoglycemia risk because insulin release is glucose-dependent (risk rises when combined with sulfonylureas or insulin) - Strong control of post-meal glucose spikes - Cardiovascular safety shown in a large outcomes trial, with no increase in major cardiac events - Can be added to basal insulin to improve control while offsetting insulin-related weight gain - Once-weekly extended-release option (Bydureon) reduces injection burden versus twice-daily dosing - In people without diabetes the appetite effect is real, but standalone weight loss has been modest and less consistent than newer agents such as [semaglutide](/compound/semaglutide) or [tirzepatide](/compound/tirzepatide) ### Tirzepatide: potential benefits - Mean body weight reduction of 20.9% at 72 weeks on 15 mg for everyone randomized (treatment-regimen estimand), 22.5% in the efficacy estimand (SURMOUNT-1, PMID: 35658024) - 36.2% of participants achieved greater than or equal to 25% body weight loss (PMID: 35658024) - Significant HbA1c reduction in type 2 diabetes (up to 2.4% at 40 weeks in the SURPASS-5 add-on-to-insulin trial) (PMID: 35133415) - Potentially superior lean mass preservation versus GLP-1-only agents due to GIP component - Dual incretin mechanism providing complementary metabolic benefits - Improved lipid profiles including triglycerides, LDL cholesterol, and HDL cholesterol - Reduction in waist circumference and markers of visceral adiposity (PMID: 37840095) ## Frequently asked ### What's the difference between Exenatide and Tirzepatide? Exenatide is a weight loss that exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the gila monster (heloderma suspectum). it shares about 53 percent of its…. Tirzepatide is a metabolic & weight loss that dual glp-1 and gip receptor agonism tirzepatide simultaneously activates two incretin receptors: the glp-1 receptor and the gip receptor. while the glp-1 receptor component…. The two differ in mechanism, half-life (Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. vs ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification), and typical dose range. ### Which has the longer half-life, Exenatide or Tirzepatide? Exenatide has a half-life of Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks.. Tirzepatide has a half-life of ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification. Longer half-lives generally mean less frequent dosing but slower on/off kinetics. ### Can you stack Exenatide and Tirzepatide? Stacking depends on mechanism overlap, safety profile, and goals. Exenatide and Tirzepatide should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds. ## See current vendor prices Listings from the vendors we track. Prices change often, so check the vendor before you buy. Exenatide prices: https://www.bodyhackguide.co/compound/exenatide?tab=prices Tirzepatide prices: https://www.bodyhackguide.co/compound/tirzepatide?tab=prices Compare all compounds: https://www.bodyhackguide.co/compare ### Before you buy Exenatide or Tirzepatide Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor. View Vendor Scorecard (https://www.bodyhackguide.co/vendors/scorecard) ## Related comparisons Retatrutide vs Tirzepatide: https://www.bodyhackguide.co/compare/retatrutide-vs-tirzepatide Tirzepatide vs Semaglutide: https://www.bodyhackguide.co/compare/tirzepatide-vs-semaglutide Mazdutide vs Tirzepatide: https://www.bodyhackguide.co/compare/mazdutide-vs-tirzepatide AOD-9604 vs Tirzepatide: https://www.bodyhackguide.co/compare/aod-9604-vs-tirzepatide 5-Amino-1MQ vs Tirzepatide: https://www.bodyhackguide.co/compare/5-amino-1mq-vs-tirzepatide **Research use only.** BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards (https://www.bodyhackguide.co/editorial-standards) and affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). BodyHackGuide (https://www.bodyhackguide.co/) Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. support@bodyhackguide.co Join our Discord: https://discord.gg/Mhq5UdRYBA r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide **Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology). Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. - Terms: https://www.bodyhackguide.co/terms - Privacy: https://www.bodyhackguide.co/privacy ## Structured data ```json [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Exenatide vs Tirzepatide" } ] }, { "@context": "https://schema.org", "@type": "WebPage", "name": "Exenatide vs Tirzepatide: Side-by-Side Comparison (2026)", "description": "Compare Exenatide vs Tirzepatide side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices.", "url": "https://www.bodyhackguide.co/compare/exenatide-vs-tirzepatide", "dateModified": "2026-10-28", "isPartOf": { "@type": "WebSite", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainEntity": { "@type": "ItemList", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@type": "Product", "name": "Exenatide", "description": "Exenatide (Byetta, Bydureon) is a synthetic exendin-4 GLP-1 receptor agonist, FDA-approved for type 2 diabetes, that lowers blood glucose and curbs appetite. Available as a twice-daily immediate-release and a once-weekly extended-release injection.", "url": "https://www.bodyhackguide.co/compound/exenatide", "category": "Weight Loss" } }, { "@type": "ListItem", "position": 2, "item": { "@type": "Product", "name": "Tirzepatide", "description": "Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with a molecular weight of 4813.45 Da and CAS number 2023788-19-2. It is a 39-amino-acid synthetic peptide based on the native GIP sequence with modifications that confer…", "url": "https://www.bodyhackguide.co/compound/tirzepatide", "category": "Metabolic & Weight Loss", "offers": { "@type": "AggregateOffer", "lowPrice": "49.00", "priceCurrency": "USD", "offerCount": 14 } } } ] } }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 273 compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What's the difference between Exenatide and Tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "Exenatide is a weight loss that exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the gila monster (heloderma suspectum). it shares about 53 percent of its…. Tirzepatide is a metabolic & weight loss that dual glp-1 and gip receptor agonism tirzepatide simultaneously activates two incretin receptors: the glp-1 receptor and the gip receptor. while the glp-1 receptor component…. The two differ in mechanism, half-life (Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. vs ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification), and typical dose range." } }, { "@type": "Question", "name": "Which has the longer half-life, Exenatide or Tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "Exenatide has a half-life of Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks.. Tirzepatide has a half-life of ~5 days (approximately 120 hours), enabled by C20 fatty diacid albumin-binding modification. Longer half-lives generally mean less frequent dosing but slower on/off kinetics." } }, { "@type": "Question", "name": "Can you stack Exenatide and Tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "Stacking depends on mechanism overlap, safety profile, and goals. Exenatide and Tirzepatide should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds." } } ] } ] ```